Last week, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2.

The U.S. Department of Health and Human Services’ (HHS) COVID-19 Vaccination Public Education Campaign, We Can Do This, resulted in an estimated $731.9 billion in societal benefits due to averted illness and related costs, resulting in a nearly $90 return in societal benefits for every $1 spent, according to research published recently in the American Journal of Preventive Medicine.

A proposed Ohio House Bill would restrict the ability of an employer to punish employees for not taking vaccines, or other medical treatments. The sponsors of the bill laid out their case during the bill’s first hearing earlier this month.

Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. 

On Wednesday, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine dose. The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults, along with the currently available data on vaccine effectiveness.

New research from Ohio State University shows the most recent variant of the COVID-19 virus “can be neutralized” by the latest vaccines, preventing a “widespread surge,” even as the state sees a winter rise set in.

On Oct. 3, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula.

Americans older than 6 months should get an updated COVID-19 booster this fall, according to a recommendation the Centers for Disease Control and Prevention issued Tuesday.

Ohio Department of Health Director Bruce Vanderhoff, M.D., MBA Thursday said he remains confident that updated COVID-19 vaccinations will continue to be readily available to Ohioans, including to those without insurance.

The Biden administration is gearing up for a fall vaccination campaign that not only includes updated COVID-19 boosters, but the annual flu shot and the newly approved RSV vaccine.

The Biden administration on Tuesday announced a $1.4 billion investment in developing the so-called next generation of COVID-19 vaccines and treatments.

Ohio Department of Health (ODH) Director Bruce Vanderhoff, MD, MBA Thursday said he is confident that the COVID-19 vaccine will continue to be readily available to Ohioans, including to those without insurance, even as the vaccine supply next week begins to transition to a more traditional healthcare model.